Isabelle de Azevedo

Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig.

Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig.

Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig.

Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig.